Immunome Up Over 24%, on Pace for Record Percent Increase -- Data Talk

Dow Jones12-15

Immunome, Inc. $(IMNM)$ is currently at $24.36, up $4.79 or 24.48%

 

--Would be highest close since March 28, 2024, when it closed at $24.68

--On pace for largest percent increase since Feb. 6, 2024, when it rose 36.91%

--Currently up three of the past four days

--Currently up two consecutive days; up 24.99% over this period

--Best two day stretch since the two days ending Oct. 6, 2025, when it rose 25.63%

--Up 32.25% month-to-date

--Up 129.38% year-to-date; on pace for best year since 2023, when it rose 384.16%

--Down 43.66% from its all-time closing high of $43.24 on Feb. 24, 2021

--Up 95.82% from 52 weeks ago (Dec. 16, 2024), when it closed at $12.44

--Would be a new 52-week closing high

--Up 338.13% from its 52-week closing low of $5.56 on April 8, 2025

--Traded as high as $25.30; highest intraday level since March 28, 2024, when it hit $25.75

--Up 29.28% at today's intraday high; largest intraday percent increase since Feb. 6, 2024, when it rose as much as 37.14%

 

All data as of 10:54:00 AM ET

 

Source: Dow Jones Market Data, FactSet

 

(END) Dow Jones Newswires

December 15, 2025 10:57 ET (15:57 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment